GGHC
NURO

Gilder Gagnon Howe & Co’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio NURO Stock Details NURO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-65
Closed -$323K – 287
2014
Q4 		$323K Buy
+65
New +$285K ﹤0.01% 233

Other funds holding NURO

BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $111M AUM 74.4% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Gilder Gagnon Howe & Co's NURO Position: Q1 2015 in Review

Gilder Gagnon Howe & Co sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q1 2015, closing a stake of 65 shares — an estimated $323K sold.

Gilder Gagnon Howe & Co first reported a position in NURO in Q4 2014 and held it in 1 quarter. The position peaked at $323K in Q4 2014. 9 funds tracked by Wall St. Rank hold NURO as of Q1 2015.

  • Gilder Gagnon Howe & Co reported no remaining NeuroMetrix, Inc. Common Stock position as of Q1 2015 after selling out during the quarter.
  • Gilder Gagnon Howe & Co sold 65 NeuroMetrix, Inc. Common Stock shares in Q1 2015, an estimated $323K.
  • Gilder Gagnon Howe & Co first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2014 and held it in 1 quarter.
  • Gilder Gagnon Howe & Co's NeuroMetrix, Inc. Common Stock position peaked at $323K in Q4 2014.
  • 9 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q1 2015.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2015, filed 30 Apr 2015.